Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Tuberculosis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 35 articles: HTML format

Single Articles

August 2022
1. HAAS DW, Abdelwahab MT, van Beek SW, Baker P, et al
   Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.
   J Infect Dis. 2022;226:147-156.
   PubMed     Abstract available
   
   
   May 2022
2. KUA KP, Chongmelaxme B, Lee S
   Association between cytomegalovirus infection and tuberculosis disease: A systematic review and meta-analysis of epidemiological studies.
   J Infect Dis. 2022 May 4. pii: 6580085. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. WALKER NF, Karim F, Moosa M, Moodley S, et al
   Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
   J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2022
4. NGO MD, Bartlett S, Bielefeldt-Ohmann H, Foo CX, et al
   A blunted GPR183/oxysterol axis during dysglycemia results in delayed recruitment of macrophages to the lung during M. tuberculosis infection.
   J Infect Dis. 2022 Mar 18. pii: 6550675. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2022
5. TEPEKULE B, Kusejko K, Zeeb M, Tarr PE, et al
   Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.
   J Infect Dis. 2022 Feb 16. pii: 6529706. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. JIA P, Zhang Y, Xu J, Zhu M, et al
   IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection.
   J Infect Dis. 2022;225:608-616.
   PubMed     Abstract available
   
   
   
7. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
   Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
   J Infect Dis. 2022 Feb 11. pii: 6526953. doi: 10.1093.
   PubMed    
   
   
   January 2022
8. ZURCHER K, Riou J, Morrow C, Ballif M, et al
   Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.
   J Infect Dis. 2022 Jan 18. pii: 6510424. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2021
9. SAHA A, Escudero J, Layouni T, Richardson B, et al
   Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum.
   J Infect Dis. 2021 Dec 20. pii: 6470923. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. GERIC C, Saroufim M, Landsman D, Richard J, et al
    Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients.
    J Infect Dis. 2021 Dec 17. pii: 6469005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. POERIO N, Caccamo N, La Manna MP, Olimpieri T, et al
    Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages.
    J Infect Dis. 2021 Dec 15. pii: 6463308. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2021
12. HLAKA L, Ozturk M, Chia JE, Jones SS, et al
    IL-4i1 regulates immune protection during Mycobacterium tuberculosis infection.
    J Infect Dis. 2021 Nov 5. pii: 6421699. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
13. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
14. LONG R, Lau A, Egedahl ML, Paulsen C, et al
    Local Transmission Plays No Important Role in the Occurrence of Multidrug-Resistant Tuberculosis in Immigrants to Canada: An In-depth Epidemiologic Analysis.
    J Infect Dis. 2021;224:1029-1038.
    PubMed     Abstract available
    
    
    
15. PIETERMAN ED, Keutzer L, van der Meijden A, van den Berg S, et al
    Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model.
    J Infect Dis. 2021;224:1039-1047.
    PubMed     Abstract available
    
    
    
16. CHEN Y, Ji L, Liu Q, Li J, et al
    Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis.
    J Infect Dis. 2021;224:889-893.
    PubMed     Abstract available
    
    
    July 2021
17. HALLIDAY A, Masonou T, Tolosa-Wright MR, Guo Y, et al
    Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis.
    J Infect Dis. 2021 Jul 31. pii: 6332782. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
18. ARRIAGA MB, Rocha MS, Nogueira B, Nascimento V, et al
    The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.
    J Infect Dis. 2021 May 19. pii: 6278117. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. PARVEEN S, Lun S, Urbanowski ME, Cardin M, et al
    Effective host-directed therapy for tuberculosis by targeted depletion of myeloid-derived suppressor cells and related cells using a diphtheria toxin-based fusion protein.
    J Infect Dis. 2021 May 6. pii: 6270734. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
20. DUFFY FJ, Olson GS, Gold ES, Jahn A, et al
    A contained Mycobacterium tuberculosis mouse infection model predicts active disease and containment in humans.
    J Infect Dis. 2021 Mar 10. pii: 6167837. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
21. MUDDE SE, Alsoud RA, van der Meijden A, Upton AM, et al
    Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data.
    J Infect Dis. 2021 Feb 19. pii: 6145049. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. RAO MUVVA J, Ahmed S, Rekha RS, Kalsum S, et al
    Immunomodulatory agents combat multidrug-resistant tuberculosis by improving antimicrobial immunity.
    J Infect Dis. 2021 Feb 19. pii: 6145048. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. DUBEY N, Khan MZ, Kumar S, Sharma A, et al
    Mycobacterium tuberculosis PPiA interacts with host integrin receptor to exacerbate disease progression.
    J Infect Dis. 2021 Feb 13. pii: 6134355. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. LAI CC, Tehrani B, Yungtum G, Hsu WT, et al
    Association between the use of statins and risk of tuberculosis: a real-world analysis.
    J Infect Dis. 2021 Feb 8. pii: 6131374. doi: 10.1093.
    PubMed    
    
    
    
25. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    PubMed     Abstract available
    
    
    January 2021
26. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2020
27. BARBOSA BOMFIM CC, Pinheiro Amaral E, Santiago-Carvalho I, Almeida Santos G, et al
    Granulocytic Myeloid-Derived Suppressor Cells Aggravate Tuberculosis Caused by Hypervirulent Mycobacteria.
    J Infect Dis. 2020 Nov 18. pii: 5989003. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2020
28. DONOVAN J, Tram TTB, Phu NH, Hiep NTT, et al
    The influence of Strongyloides stercoralis co-infection on the presentation, pathogenesis and outcome of tuberculous meningitis.
    J Infect Dis. 2020 Oct 26. pii: 5940016. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. HJORT K, Juren P, Toro JC, Hoffner S, et al
    Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment.
    J Infect Dis. 2020 Oct 12. pii: 5921146. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
    J Infect Dis. 2020 Oct 7. pii: 5918919. doi: 10.1093.
    PubMed    
    
    
    June 2020
31. DUTTA NK, Karakousis PC
    Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?
    J Infect Dis. 2020;222:336-337.
    PubMed    
    
    
    March 2020
32. KAUSHAL D
    The Comeback Kid: BCG.
    J Infect Dis. 2020;221:1031-1032.
    PubMed    
    
    
    January 2020
33. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2019
34. HU Z, Lowrie DB, Fan XY
    Statins as adjunctive therapy against tuberculosisthe balance between statin-induced anti-TB effect and trained immunity suppression.
    J Infect Dis. 2019 Dec 24. pii: 5686380. doi: 10.1093.
    PubMed    
    
    
    November 2019
35. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: